This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleihues, P. Articles by Ohgaki, H. Search for Related Content PubMed PubMed Citation Articles by Kleihues, P. Articles by Ohgaki, H. Social Bookmarking                   What's this?

Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors

International Agency for Research on Cancer, World Health Organization, 69372 Lyon, France

Hiroko Ohgaki

International Agency for Research on Cancer, World Health Organization, 69372 Lyon, France

Astrocytic brain tumors are the most frequent human gliomas and they include a wide range of neoplasms with distinct clinical, histopathologic, and genetic features. Diffuse astrocytomas are predominantly located in the cerebral hemispheres of adults and have an inherent tendency to progress to anaplastic astrocytoma and (secondary) glioblastoma. The majority of glioblastomas develop de novo (primary glioblastomas), without an identifiable less-malignant precursor lesion. These subtypes of glioblastoma evolve through different genetic pathways, affect patients at different ages, and are likely to differ in their responses to therapy. Primary glioblastomas occur in older patients and typically show epidermal growth factor receptor (EGFR) overexpression, PTEN mutations, p16 deletions, and, less frequently, MDM2 amplification. Secondary glioblastomas develop in younger patients and often contain TP53 mutations as their earliest detectable alteration. Morphologic variants of glioblastoma were shown to have intermediate clinical and genetic profiles. The giant cell glioblastoma clinically and genetically occupies a hybrid position between primary (de novo) and secondary glioblastomas. Gliosarcomas show identical gene mutations in the gliomatous and sarcomatous tumor components, which strongly supports the concept that there is a monoclonal origin for gliosarcomas and an evolution of the sarcomatous component due to aberrant mesenchymal differentiation in a highly malignant astrocytic neoplasm.

Key Words: Primary glioblastoma • secondary glioblastoma • glioma progression • giant cell glioblastoma • gliosarcoma • p53 • EGFR • PTEN • p16 • MDM2

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Krex, B. Klink, C. Hartmann, A. von Deimling, T. Pietsch, M. Simon, M. Sabel, J. P. Steinbach, O. Heese, G. Reifenberger, et al. Long-term survival with glioblastoma multiforme Brain, October 1, 2007; 130(10): 2596 - 2606. [Abstract] [Full Text] [PDF]

				M. Friedman, E. Nordberg, I. Hoiden-Guthenberg, H. Brismar, G.P. Adams, F.Y. Nilsson, J. Carlsson, and S. Stahl Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor Protein Eng. Des. Sel., April 23, 2007; (2007) gzm011v1. [Abstract] [Full Text] [PDF]

				J. K. Wiencke, K. Aldape, A. McMillan, J. Wiemels, M. Moghadassi, R. Miike, K. T. Kelsey, J. Patoka, J. Long, and M. Wrensch Molecular Features of Adult Glioma Associated with Patient Race/Ethnicity, Age, and a Polymorphism in O6-Methylguanine-DNA-Methyltransferase Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1774 - 1783. [Abstract] [Full Text] [PDF]

				H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P.-L. Di Patre, C. Burkhard, D. Schuler, N. M. Probst-Hensch, P. C. Maiorka, et al. Genetic Pathways to Glioblastoma: A Population-Based Study Cancer Res., October 1, 2004; 64(19): 6892 - 6899. [Abstract] [Full Text] [PDF]

				P. D Inskip, R. E Tarone, E. E Hatch, T. C Wilcosky, H. A Fine, P. M Black, J. S Loeffler, W. R Shapiro, R. G Selker, and M. S Linet Sociodemographic indicators and risk of brain tumours Int. J. Epidemiol., April 1, 2003; 32(2): 225 - 233. [Abstract] [Full Text] [PDF]

				M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger Epidemiology of primary brain tumors: Current concepts and review of the literature Neuro-oncol, October 1, 2002; 4(4): 278 - 299. [Abstract] [PDF]

				T. P. Hecker, J. R. Grammer, G. Y. Gillespie, J. Stewart Jr., and C. L. Gladson Focal Adhesion Kinase Enhances Signaling through the Shc/Extracellular Signal-regulated Kinase Pathway in Anaplastic Astrocytoma Tumor Biopsy Samples Cancer Res., May 1, 2002; 62(9): 2699 - 2707. [Abstract] [Full Text] [PDF]

				G. J. P. L. Kops, R. H. Medema, J. Glassford, M. A. G. Essers, P. F. Dijkers, P. J. Coffer, E. W.-F. Lam, and B. M. T. Burgering Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors Mol. Cell. Biol., April 1, 2002; 22(7): 2025 - 2036. [Abstract] [Full Text] [PDF]

				M. Nakamura, T. Watanabe, Y. Yonekawa, P. Kleihues, and H. Ohgaki Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C {->} A:T mutations of the TP53 tumor suppressor gene Carcinogenesis, October 1, 2001; 22(10): 1715 - 1719. [Abstract] [Full Text] [PDF]

				P. Chen, K. Aldape, J. K. Wiencke, K. T. Kelsey, R. Miike, R. L. Davis, J. Liu, A. Kesler-Diaz, M. Takahashi, and M. Wrensch Ethnicity Delineates Different Genetic Pathways in Malignant Glioma Cancer Res., May 1, 2001; 61(10): 3949 - 3954. [Abstract] [Full Text]